Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways

Gastroenterology

Volumn 141, Issue 5, 2011, Pages 1887-1896.e2

  Jarry, Anne ^a   Bossard, Céline ^a,b   Sarrabayrouse, Guillaume ^c   Mosnier, Jean François ^a,b   Laboisse, Christian L ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Team 12   (France)

Author keywords

Crohn's Disease; Human Tissue Samples; Inflammasome; Inflammation; Mucosa Resident Cells

Indexed keywords

CASPASE INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 18; RECOMBINANT INTERLEUKIN 18; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; YVAD FMK; ZVAD;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COLON; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MACROPHAGE; MALE; MUCOSA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH1 CELL;

EID: 80054875951     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.08.002     Document Type: Article

References (33)

1. Di Sabatino A, Pickard KM, Rampton D, et al. Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa. Gut 2008;57:605-612. (Pubitemid 351579972)
2. Jarry A, Bossard C, Bou-Hanna C, et al. Mucosal IL-10 and TGFbeta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J Clin Invest 2008;118:1132-1142. (Pubitemid 351364620)
3. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-521. (Pubitemid 46348505)
4. Monteleone G, Del Vecchio Blanco G, Monteleone I, et al. Posttranscriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 2005;129:1420-1429. (Pubitemid 41597384)
5. Correa I, Veny M, Esteller M, et al. Defective IL-10 production in severe phenotypes of Crohn's disease. J Leukoc Biol 2009;85:896-903.
6. Noguchi E, Homma Y, Kang X, et al. A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat Immunol 2009;10:471-479.
7. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009;361:2033-2045.
8. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133-146. (Pubitemid 37328691)
9. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561-574. (Pubitemid 38692523)
10. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009;27:229-265.
11. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112:1169-1178. (Pubitemid 27157528)
12. Pizarro TT, Michie MH, Bentz M, et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999;162:6829-6835. (Pubitemid 29309411)
13. Fuss IJ, Becker C, Yang Z, et al. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis 2006;12:9-15. (Pubitemid 43032445)
14. Jarry A, Bach-Ngohou K, Masson D, et al. Human colonic myocytes are involved in postischemic inflammation through ADAM17 dependent TNFalpha production. Br J Pharmacol 2006;147:64-72. (Pubitemid 43069097)
15. Tsiavou A, Degiannis D, Hatziagelaki E, et al. Flow cytometric detection of intracellular IL-12 release: in vitro effect of widely used immunosuppressants. Int Immunopharmacol 2002;2:1713-1720. (Pubitemid 35284609)
16. te Velde AA, van Kooyk Y, Braat H, et al. Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur J Immunol 2003;33:143-151. (Pubitemid 36157652)
17. Novick D, Kim SH, Fantuzzi G, et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999;10:127-136. (Pubitemid 29077390)
18. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993;90:770-774. (Pubitemid 23028947)
19. Hahm KB, Im YH, Parks TW, et al. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 2001;49:190-198. (Pubitemid 32675110)
20. Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10-/-) mice and intestinal inflammation. Am J Physiol 2000;278:G829-G833. (Pubitemid 30439159)
21. Ludviksson BR, Ehrhardt RO, Strober W. TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J Immunol 1997;159:3622-3628. (Pubitemid 127482122)
22. Fuss IJ, Boirivant M, Lacy B, et al. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J Immunol 2002;168:900-908. (Pubitemid 34049594)
23. Kitani A, Fuss IJ, Nakamura K, et al. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1- mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J Exp Med 2000;192:41-52. (Pubitemid 30470805)
24. Castagliuolo I, Brun P, Tormen D, et al. Lymphocytes endowed with colon-selective homing and engineered to produce TGF-beta1 prevent the development of dinitrobenzene sulphonic acid colitis. Eur J Gastroenterol Hepatol 2003;15:1257-1265. (Pubitemid 39049667)
25. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-1290.
26. Fantuzzi G, Reed DA, Dinarello CA. IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest 1999;104:761-767. (Pubitemid 29536361)
27. Bliss SK, Butcher BA, Denkers EY. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J Immunol 2000;165:4515-4521.
28. Quinones M, Ahuja SK, Melby PC, et al. Preformed membraneassociated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite. J Exp Med 2000;192:507-516.
29. Jarry A, Vallette G, Cassagnau E, et al. Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer. Gut 1999;45:246-251. (Pubitemid 29333774)
30. McAlindon ME, Hawkey CJ, Mahida YR. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 1998; 42:214-219. (Pubitemid 28212176)
31. Barbulescu K, Becker C, Schlaak JF, et al. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFNgamma promoter in primary CD4+ T lymphocytes. J Immunol 1998;160:3642-3647. (Pubitemid 28176063)
32. Helmby H, Grencis RK. IFN-gamma-independent effects of IL-12 during intestinal nematode infection. J Immunol 2003;171:3691-3696. (Pubitemid 37254573)
33. Wang ZE, Zheng, Corry DB, et al. Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci U S A 1994;91:12932-12936.